.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
Dow
Harvard Business School
Citi
Chubb
AstraZeneca
McKinsey
US Army
Daiichi Sankyo

Generated: September 20, 2017

DrugPatentWatch Database Preview

Pharmachemie Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMACHEMIE, and what generic and branded alternatives to PHARMACHEMIE drugs are available?

PHARMACHEMIE has fifteen approved drugs.



Summary for Applicant: Pharmachemie

Patents:0
Tradenames:9
Ingredients:8
NDAs:15
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077269-003Oct 14, 2004APRXNoYes► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION040843-004Jan 11, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION040843-001Jan 11, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION040843-003Feb 27, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077269-001Oct 14, 2004APRXNoYes► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-003May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077679-001Feb 25, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077269-004Dec 28, 2007APRXNoYes► Subscribe► Subscribe► Subscribe
Pharmachemie Usa
LEUCOVORIN CALCIUM
leucovorin calcium
INJECTABLE;INJECTION089915-001Apr 17, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
BLEOMYCIN SULFATE
bleomycin sulfate
INJECTABLE;INJECTION065201-001Dec 13, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Novartis
Cantor Fitzgerald
Boehringer Ingelheim
Cerilliant
Chubb
Farmers Insurance
Argus Health
QuintilesIMS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot